{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:04:18Z","timestamp":1784084658930,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13592-0","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:45:27Z","timestamp":1779295527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relapse of HIV-associated multicentric Castleman disease temporally associated with acute coronavirus disease 2019: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Hiroki","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yota","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seowoong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiichiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishiro","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ajisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Gomikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Hishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"16","key":"13592_CR1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood.2019000931","volume":"135","author":"A Dispenzieri","year":"2020","unstructured":"Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020;135(16):1353\u201364. https:\/\/doi.org\/10.1182\/blood.2019000931.","journal-title":"Blood"},{"issue":"1","key":"13592_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05311.x","volume":"129","author":"C Casper","year":"2005","unstructured":"Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129(1):3\u201317. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05311.x.","journal-title":"Br J Haematol"},{"issue":"5","key":"13592_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/01.cco.0000239884.05914.13","volume":"18","author":"R Sullivan","year":"2006","unstructured":"Sullivan R, Dezube BJ, Koon HB. Signal transduction targets in Kaposi\u2019s sarcoma. Curr Opin Oncol. 2006;18(5):456\u201362. https:\/\/doi.org\/10.1097\/01.cco.0000239884.05914.13.","journal-title":"Curr. Opin. Oncol"},{"issue":"1","key":"13592_CR4","first-page":"25","volume":"10","author":"EE Mylona","year":"2008","unstructured":"Mylona EE, Baraboutis IG, Lekakis LJ, Georgiou O, Papastamopoulos V, Skoutelis A. Multicentric Castleman\u2019s disease in HIV infection: a systematic review of the literature. AIDS Rev. 2008;10(1):25\u201335.","journal-title":"AIDS Rev"},{"issue":"1","key":"13592_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","volume":"10","author":"E Oksenhendler","year":"1996","unstructured":"Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, et al. Multicentric Castleman disease in HIV infection. AIDS. 1996;10(1):61\u201368. https:\/\/doi.org\/10.1097\/00002030-199601000-00009.","journal-title":"AIDS"},{"issue":"18","key":"13592_CR6","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1200\/JCO.2010.34.1909","volume":"29","author":"M Bower","year":"2011","unstructured":"Bower M, Newsom-Davis T, Naresh K, Merchant S, Lee B, Gazzard B, et al. Clinical features and outcome in HIV-associated multicentric Castleman\u2019s disease. J Clin Oncol. 2011;29(18):2481\u201386. https:\/\/doi.org\/10.1200\/JCO.2010.34.1909.","journal-title":"JCO"},{"key":"13592_CR7","unstructured":"World Health Organization: WHO COVID-19 dashboard. 2024. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c. Accessed\u00a0 17 Jul 2025."},{"key":"13592_CR8","unstructured":"World Health Organization. WHO COVID-19 dashboard. 2024. https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c.\u00a0 Accessed\u00a0 17 Jul 2025."},{"key":"13592_CR9","doi-asserted-by":"publisher","unstructured":"Ng WH, Tipih T, Makoah NA, Vermeulen J-G, Goedhals D, Sempa JB, et al. Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. mBio. 2021;12(1):e03647\u201320. https:\/\/doi.org\/10.1128\/mBio.03647-20.","DOI":"10.1128\/mBio.03647-20"},{"issue":"4","key":"13592_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/annonc\/mdn697","volume":"20","author":"T Powles","year":"2009","unstructured":"Powles T, Stebbing J, Bazeos A, Hatzimichael E, Mandalia S, Nelson M, et al. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman\u2019s disease. Ann Oncol. 2009;20(4):775\u201379. https:\/\/doi.org\/10.1093\/annonc\/mdn697.","journal-title":"Ann Oncol"},{"key":"13592_CR11","doi-asserted-by":"publisher","unstructured":"Kimani SM, Painschab MS, Horner M-J, Muchengeti M, Fedoriw Y, Shiels MS, et al. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV. 2020;7(9):e641\u201351. https:\/\/doi.org\/10.1016\/S2352-30182030118-1.","DOI":"10.1016\/S2352-30182030118-1"},{"issue":"1","key":"13592_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","volume":"7","author":"A Carbone","year":"2021","unstructured":"Carbone A, Borok M, Damania B, Gloghini A, Polizzotto MN, Jayanthan RK, et al. Castleman disease. Nat Rev Dis Primers. 2021;7(1):84. https:\/\/doi.org\/10.1038\/s41572-021-00317-7.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"13592_CR13","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1182\/blood-2018-11-852442","volume":"133","author":"E Oksenhendler","year":"2019","unstructured":"Oksenhendler E, Boutboul D, Galicier L. Kaposi sarcoma\u2013associated herpesvirus\/human herpesvirus 8\u2013associated lymphoproliferative disorders. Blood. 2019;133(11):1186\u201390. https:\/\/doi.org\/10.1182\/blood-2018-11-852442.","journal-title":"Blood"},{"issue":"7","key":"13592_CR14","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","volume":"99","author":"E Oksenhendler","year":"2002","unstructured":"Oksenhendler E, Boulanger E, Galicier L, Du M-Q, Dupin N, Diss TC, et al. High incidence of Kaposi sarcoma\u2013associated herpesvirus\u2013related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002;99(7):2331\u201336. https:\/\/doi.org\/10.1182\/blood.V99.7.2331.","journal-title":"Blood"},{"issue":"5","key":"13592_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/CCO.0b013e328349c233","volume":"23","author":"D Reddy","year":"2011","unstructured":"Reddy D, Mitsuyasu R. HIV-associated multicentric Castleman disease. Curr Opin Oncol. 2011;23(5):475\u201381. https:\/\/doi.org\/10.1097\/CCO.0b013e328349c233.","journal-title":"Curr. Opin. Oncol"},{"issue":"5","key":"13592_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/14397595.2019.1704983","volume":"30","author":"M Murakami","year":"2020","unstructured":"Murakami M, Johkoh T, Hayashi S, Ohshima S, Mizuki M, Nakatsuka S-I, et al. Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan. Mod Rheumatol. 2020;30(5):843\u201351. https:\/\/doi.org\/10.1080\/14397595.2019.1704983.","journal-title":"Mod Rheumatol"},{"issue":"9","key":"13592_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/14787210.2023.2247161","volume":"21","author":"R Patel","year":"2023","unstructured":"Patel R, Lurain K, Yarchoan R, Ramaswami R. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies. Expert Rev Anti Infect Ther. 2023;21(9):929\u201341. https:\/\/doi.org\/10.1080\/14787210.2023.2247161.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"23","key":"13592_CR18","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","volume":"28","author":"F van Rhee","year":"2010","unstructured":"van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, et al. Siltuximab, a novel anti\u2013interleukin-6 monoclonal antibody, for Castleman\u2019s disease. J Clin Oncol. 2010;28(23):3701\u201308. https:\/\/doi.org\/10.1200\/JCO.2009.27.2377.","journal-title":"JCO"},{"issue":"26","key":"13592_CR19","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1182\/blood-2013-08-519959","volume":"122","author":"MN Polizzotto","year":"2013","unstructured":"Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V, et al. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood. 2013;122(26):4189\u201398. https:\/\/doi.org\/10.1182\/blood-2013-08-519959.","journal-title":"Blood"},{"issue":"6","key":"13592_CR20","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1182\/bloodadvances.2020004058","volume":"5","author":"R Ramaswami","year":"2021","unstructured":"Ramaswami R, Lurain K, Polizzotto MN, Ekwede I, Waldon K, Steinberg SM, et al. Robert Yarchoan. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases. Blood Adv. 2021;5(6):1660\u201370. https:\/\/doi.org\/10.1182\/bloodadvances.2020004058.","journal-title":"Blood Adv"},{"issue":"22","key":"13592_CR21","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","volume":"25","author":"L G\u00e9rard","year":"2007","unstructured":"G\u00e9rard L, B\u00e9rezn\u00e9 A, Galicier L, Meignin V, Obadia M, Castro ND, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus\u2013associated Multicentric Castleman\u2019s disease: ANRS 117 CastlemaB trial. J Clin Oncol. 2007;25(22):3350\u201356. https:\/\/doi.org\/10.1200\/JCO.2007.10.6732.","journal-title":"JCO"},{"issue":"22","key":"13592_CR22","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1182\/blood-2010-07-290213","volume":"116","author":"M Bower","year":"2010","unstructured":"Bower M. How I treat HIV-associated multicentric Castleman disease. Blood. 2010;116(22):4415\u201321. https:\/\/doi.org\/10.1182\/blood-2010-07-290213.","journal-title":"Blood"},{"issue":"1","key":"13592_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13054-020-03252-3","volume":"24","author":"P Le Balc\u2019h","year":"2020","unstructured":"Le Balc\u2019h P, Pinceaux K, Pronier C, Seguin P, Tadi\u00e9 J-M, Reizine F. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care. 2020;24(1):530. https:\/\/doi.org\/10.1186\/s13054-020-03252-3.","journal-title":"Crit Care"},{"key":"13592_CR24","doi-asserted-by":"publisher","first-page":"204062072412295","DOI":"10.1177\/20406207241229584","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yin X, Xu D, Lv Y, Zhu L, Yang M, et al. When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China. Ther Adv Hematol. 2024;15:20406207241229584. https:\/\/doi.org\/10.1177\/20406207241229584.","journal-title":"Ther Adv Hematol"},{"issue":"13","key":"13592_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/09564624251355834","volume":"36","author":"Z Orta","year":"2025","unstructured":"Orta Z, Benli A, \u00c7a\u011fatay AA, Ba\u015faran S, Erdem S, Be\u015fi\u015fik S. Hemophagocytic lymphohistiocytosis syndrome (HLH) in HIV-associated Kaposi sarcoma patients: the first case series from a single center in T\u00fcrkiye. Int J STD AIDS. 2025;36(13):946\u201350. https:\/\/doi.org\/10.1177\/09564624251355834.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"13592_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","volume":"86","author":"J Soulier","year":"1995","unstructured":"Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease [see comments]. Blood. 1995;86(4):1276\u201380. https:\/\/doi.org\/10.1182\/blood.V86.4.1276.bloodjournal8641276.","journal-title":"Blood"},{"issue":"9","key":"13592_CR27","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/v12091034","volume":"12","author":"G Broussard","year":"2020","unstructured":"Broussard G, Damania B. Blossom Damania. Regulation of KSHV latency and lytic reactivation. Viruses. 2020;12(9):1034. https:\/\/doi.org\/10.3390\/v12091034.","journal-title":"Viruses"},{"issue":"2","key":"13592_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1006\/viro.2000.0196","volume":"269","author":"H Katano","year":"2000","unstructured":"Katano H, Sato Y, Kurata T, Mori S, Sata T. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi\u2019s sarcoma, and Multicentric Castleman\u2019s disease. Virology. 2000;269(2):335\u201344. https:\/\/doi.org\/10.1006\/viro.2000.0196.","journal-title":"Virology"},{"issue":"4","key":"13592_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1634\/theoncologist.2010-0212","volume":"16","author":"HE El-Osta","year":"2011","unstructured":"El-Osta HE, Kurzrock R. Castleman\u2019s disease: from basic mechanisms to molecular therapeutics. Oncologist. 2011;16(4):497\u2013511. https:\/\/doi.org\/10.1634\/theoncologist.2010-0212.","journal-title":"The Oncologist"},{"key":"13592_CR30","doi-asserted-by":"publisher","first-page":"104986","DOI":"10.1016\/j.ebiom.2024.104986","volume":"100","author":"H Lambarey","year":"2024","unstructured":"Lambarey H, Blumenthal MJ, Chetram A, Joyimbana W, Jennings L, Orrell C, et al. Reactivation of Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients. EBioMedicine. 2024;100:104986. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104986.","journal-title":"EBioMedicine"},{"key":"13592_CR31","doi-asserted-by":"publisher","unstructured":"Leoni E, Cerati M, Finzi G, Lombardo M, Sessa F. COVID-19 and HHV8 first spotted together: an affair under electron microscopy. J Eur Acad Dermatol Venereol. 2021;35(5):e311\u201312. https:\/\/doi.org\/10.1111\/jdv.17123.","DOI":"10.1111\/jdv.17123"},{"issue":"11","key":"13592_CR32","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1002\/jmv.27994","volume":"94","author":"J Chen","year":"2022","unstructured":"Chen J, Song J, Dai L, Post SR, Qin Z. SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era? J Med Virol. 2022;94(11):5103\u201311. https:\/\/doi.org\/10.1002\/jmv.27994.","journal-title":"J Med VirolJournal Med Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13592-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13592-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13592-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:27:20Z","timestamp":1784082440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13592-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13592"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13592-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. Written informed consent was obtained from the patient for participation in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient gave his written informed consent for the publication of the clinical details and images in this manuscript. A copy of the signed consent form is available for review by the journal\u2019s editorial office upon request.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1343"}}